These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16087359)

  • 41. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
    Mula M; Trimble MR; Sander JW
    Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levetiracetam add-on therapy in Japanese patients with refractory partial epilepsy.
    Tanaka S; Tanaka T
    Epileptic Disord; 2013 Jun; 15(2):132-41. PubMed ID: 23774199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The management of epilepsy in a hospital for people with a learning disability.
    Carvill S; Clarke D; Cassidy G
    Seizure; 1999 May; 8(3):175-80. PubMed ID: 10356377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Seizure freedom is not adversely affected by early discontinuation of concomitant anti-epileptic drugs in the EULEV cohort of levetiracetam users.
    Droz-Perroteau C; Marchal C; Dureau-Pournin C; Lassalle R; Jové J; Robinson P; Lavernhe G; Vespignani H; Moore N; Fourrier-Réglat A;
    Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1183-9. PubMed ID: 22972760
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A; Brodie MJ
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticonvulsant drugs for generalized tonic-clonic epilepsy.
    Coppola G; Piccorossi A; Operto FF; Verrotti A
    Expert Opin Pharmacother; 2017 Jun; 18(9):925-936. PubMed ID: 28481729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some common issues in the use of antiepileptic drugs.
    Asconapé JJ
    Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiepileptic drug therapy for adults: when to initiate and how to choose.
    Sirven JI
    Mayo Clin Proc; 2002 Dec; 77(12):1367-75. PubMed ID: 12479527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The teratogenicity of the newer antiepileptic drugs - an update.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
    Acta Neurol Scand; 2014 Oct; 130(4):234-8. PubMed ID: 25040242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability.
    Simister RJ; Sander JW; Koepp MJ
    Epilepsy Behav; 2007 Mar; 10(2):336-9. PubMed ID: 17267290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom.
    Verdian L; Yi Y
    Seizure; 2010 Jan; 19(1):1-11. PubMed ID: 19942457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of health status in epilepsy using the EQ-5D questionnaire: a prospective, observational, 6-month study of adjunctive therapy with anti-epileptic drugs.
    Selai CE; Trimble MR; Price MJ; Remak E
    Curr Med Res Opin; 2005 May; 21(5):733-9. PubMed ID: 15969872
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Teratogenic potential of antiepileptic drugs in the zebrafish model.
    Lee SH; Kang JW; Lin T; Lee JE; Jin DI
    Biomed Res Int; 2013; 2013():726478. PubMed ID: 24324971
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long term retention of retigabine in a cohort of people with drug resistant epilepsy.
    Wehner T; Chinnasami S; Novy J; Bell GS; Duncan JS; Sander JW
    Seizure; 2014 Nov; 23(10):878-81. PubMed ID: 25175006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy.
    Blum D; Meador K; Biton V; Fakhoury T; Shneker B; Chung S; Mills K; Hammer A; Isojärvi J
    Neurology; 2006 Aug; 67(3):400-6. PubMed ID: 16894098
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of topiramate and lamotrigine: a perspective on quality of life.
    Kaiser S; Selai CE; Trimble MR
    Seizure; 2002 Sep; 11(6):356-60. PubMed ID: 12160662
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Newer antiepileptic drugs].
    Matsuura M
    No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transient improvement after brief antiepileptic drug withdrawal in the epilepsy monitoring unit--possible relationship to AED tolerance.
    Azar NJ; Lagrange AH; Wang L; Song Y; Abou-Khalil BW
    Epilepsia; 2010 May; 51(5):811-7. PubMed ID: 20067500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.